SCHEMBL19079677

SCHEMBL19079677

Cc1sc2nc(SCC(=O)c3ccccc3)n(C3CC3)c(=O)c2c1C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 1/20 0.64
▸ GAA P10253 3/20 0.58
▸ CYP2C9 P11712 2/20 0.56
▸ CYP3A4 P08684 1/20 0.56
▸ ABCB1 P08183 1/20 0.56
▸ ALDH1A1 P00352 5/20 0.55
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ L3MBTL1 Q9Y468 3/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ NPSR1 Q6W5P4 4/20 0.51
▸ MAPT P10636 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ TSHR P16473 2/20 0.51
▸ HPGD P15428 1/20 0.51
▸ LMNA P02545 3/20 0.50
▸ ATM Q13315 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ POLB P06746 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079860 0.84 PDE4D (0.67) PDE4DGAACYP2C9ALDH1A1SMN1; SMN2
SCHEMBL19079789 0.82 KDM4E (0.64) PDE4DGAACYP2C9CYP3A4ABCB1
SCHEMBL19079736 0.82 PDE4D (0.68) PDE4DABCB1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL19079747 0.80 KDM4E (0.75) PDE4DGAAALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL19079760 0.79 KDM4E (0.64) PDE4DALDH1A1SMN1; SMN2L3MBTL1KDM4E
SCHEMBL19079757 0.79 PDE4D (0.58) PDE4DABCB1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL19079691 0.78 PDE4D (1.00) PDE4DGAACYP2C9ALDH1A1SMN1; SMN2
SCHEMBL19079703 0.78 PDE4D (0.64) PDE4DGAACYP2C9ALDH1A1SMN1; SMN2
SCHEMBL19090417 0.78 PDE4D (0.41) PDE4DGAACYP2C9CYP3A4ABCB1
SCHEMBL20228922 0.77 ALDH1A1 (0.72) GAACYP2C9ABCB1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase VANDERBILT UNIVERSITY (US) 2019-06-25 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase PDE4A, PDE4B, PDE7A PDE4D 6/4885GAA 923/4885CYP2C9 4198/4885
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase PDE4A, PDE4B, PDE7A PDE4D 6/4885GAA 923/4885CYP2C9 4198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback